Last updated on July 2019

A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation


Brief description of study

This study will investigate if nivolumab will improve recurrence-free survival (RFS) compared to placebo in participants with HCC who have undergone complete resection or have achieved a complete response after local ablation, and who are at high risk of recurrence

Clinical Study Identifier: NCT03383458

Find a site near you

Start Over

Pinnacle Research Group, Llc

Anniston, AL United States
  Connect »

Local Institution

Hiroshima-Shi, Japan
  Connect »

Local Institution

Kanazawa-shi, Japan
  Connect »

Local Institution

Tokushima-shi, Japan
  Connect »

Local Institution

Daegu, Korea, Republic of
  Connect »

Local Institution

Jeonnam, Korea, Republic of
  Connect »

Local Institution

Seoul, Korea, Republic of
  Connect »

Local Institution

Kawasaki-shi, Japan
  Connect »

Local Institution

Gyeongsangnam-do, Korea, Republic of
  Connect »

Local Institution

Montpellier Cedex 5, France
  Connect »

Local Institution

Kumamoto-shi, Japan
  Connect »

Local Institution

Musashino-shi, Japan
  Connect »

Local Institution

Nice cedex 3, France
  Connect »

Local Institution

Reims Cedex, France
  Connect »

Local Institution

Lyon Cedex 4, France
  Connect »

Local Institution

Nishinomiya-shi, Japan
  Connect »

Local Institution

Seongnam-si, Korea, Republic of
  Connect »

Mayo Clinic Hospital

Phoenix, AZ United States
  Connect »

Local Institution

St. Petersburg, Russian Federation
  Connect »

UCLA School Of Medicine

Los Angeles, CA United States
  Connect »

Stanford Cancer Center

Palo Alto, CA United States
  Connect »

Local Institution

Rennes Cedex 9, France
  Connect »

Local Institution

Osaka-sayama, Japan
  Connect »

Local Institution

Suwon-si, Korea, Republic of
  Connect »

McGuire VA Medical Center

Richmond, VA United States
  Connect »

Local Institution

Montreal, QC Canada
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Donostia-San Sebastian, Spain
  Connect »

Local Institution

Manchester, United Kingdom
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

Local Institution

Impact Migration, Belgium
  Connect »

Local Institution

Sao Jose do Rio Preto, Brazil
  Connect »

Local Institution

Singapore, Singapore
  Connect »

Local Institution

Los Angeles, CA United States
  Connect »

Local Institution

Vallejo, CA United States
  Connect »

Local Institution

Aurora, CO United States
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Mayo Clinic Hospital Rochester

Rochester, MN United States
  Connect »

Local Institution

Reno, NV United States
  Connect »

White Plains Hospital

New York, NY United States
  Connect »

Local Institution

Cleveland, OH United States
  Connect »

Local Institution

Blacktown, Australia
  Connect »

Local Institution

Belo Horizonte, Brazil
  Connect »

Local Institution

Cerqueira Cesar, Brazil
  Connect »

Local Institution

Sao Jose Do Rio Preto, Brazil
  Connect »

CHU Estaing

Clermont-Ferrand, France
  Connect »

Hopital Henri Mondor

Creteil Cedex, France
  Connect »

Local Institution

Frankfurt am Main, Germany
  Connect »

Local Institution

Hong Kong, Hong Kong
  Connect »

Local Institution

Goyang-si, Korea, Republic of
  Connect »

Local Institution

San Luis Potosi, Mexico
  Connect »

Local Institution

Auckland, New Zealand
  Connect »

Local Institution

San Juan, Puerto Rico
  Connect »

Local Institution

Leningrad Region, Russian Federation
  Connect »

Local Institution

Dallas, TX United States
  Connect »

CHU de Nancy Hopitaux de Brabois

Vandoeuvre Les Nancy Cedex, France
  Connect »

Local Institution

San Antonio, TX United States
  Connect »

Local Institution

Maastricht, Netherlands
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.